Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Transglutaminases in Monocytes and Macrophages.

Sun H, Kaartinen MT.

Med Sci (Basel). 2018 Dec 11;6(4). pii: E115. doi: 10.3390/medsci6040115. Review.

2.

Transglutaminase activity regulates differentiation, migration and fusion of osteoclasts via affecting actin dynamics.

Sun H, Kaartinen MT.

J Cell Physiol. 2018 Sep;233(9):7497-7513. doi: 10.1002/jcp.26603. Epub 2018 Apr 16.

PMID:
29663380
3.

Mineralization-inhibiting effects of transglutaminase-crosslinked polymeric osteopontin.

Hoac B, Nelea V, Jiang W, Kaartinen MT, McKee MD.

Bone. 2017 Aug;101:37-48. doi: 10.1016/j.bone.2017.04.007. Epub 2017 Apr 18.

PMID:
28428079
4.

Transglutaminases factor XIII-A and TG2 regulate resorption, adipogenesis and plasma fibronectin homeostasis in bone and bone marrow.

Mousa A, Cui C, Song A, Myneni VD, Sun H, Li JJ, Murshed M, Melino G, Kaartinen MT.

Cell Death Differ. 2017 May;24(5):844-854. doi: 10.1038/cdd.2017.21. Epub 2017 Apr 7.

5.

Factor XIII-A transglutaminase deficient mice show signs of metabolically healthy obesity on high fat diet.

Myneni VD, Mousa A, Kaartinen MT.

Sci Rep. 2016 Oct 19;6:35574. doi: 10.1038/srep35574.

6.

Transglutaminase 2--a novel inhibitor of adipogenesis.

Myneni VD, Melino G, Kaartinen MT.

Cell Death Dis. 2015 Aug 27;6:e1868. doi: 10.1038/cddis.2015.238.

7.

Cellular Factor XIIIA Transglutaminase Localizes in Caveolae and Regulates Caveolin-1 Phosphorylation, Homo-oligomerization and c-Src Signaling in Osteoblasts.

Wang S, Kaartinen MT.

J Histochem Cytochem. 2015 Nov;63(11):829-41. doi: 10.1369/0022155415597964. Epub 2015 Jul 31.

8.
9.

Extracellular matrix mineralization in murine MC3T3-E1 osteoblast cultures: an ultrastructural, compositional and comparative analysis with mouse bone.

Addison WN, Nelea V, Chicatun F, Chien YC, Tran-Khanh N, Buschmann MD, Nazhat SN, Kaartinen MT, Vali H, Tecklenburg MM, Franceschi RT, McKee MD.

Bone. 2015 Feb;71:244-56. doi: 10.1016/j.bone.2014.11.003. Epub 2014 Nov 13.

PMID:
25460184
10.

Factor XIII-A transglutaminase acts as a switch between preadipocyte proliferation and differentiation.

Myneni VD, Hitomi K, Kaartinen MT.

Blood. 2014 Aug 21;124(8):1344-53. doi: 10.1182/blood-2013-12-543223. Epub 2014 Jun 16.

11.

Transglutaminase regulation of cell function.

Eckert RL, Kaartinen MT, Nurminskaya M, Belkin AM, Colak G, Johnson GV, Mehta K.

Physiol Rev. 2014 Apr;94(2):383-417. doi: 10.1152/physrev.00019.2013. Review.

12.

Detyrosinated Glu-tubulin is a substrate for cellular Factor XIIIA transglutaminase in differentiating osteoblasts.

Wang S, Cui C, Hitomi K, Kaartinen MT.

Amino Acids. 2014 Jun;46(6):1513-26. doi: 10.1007/s00726-014-1719-x. Epub 2014 Mar 19.

PMID:
24643364
13.

Circulating undercarboxylated osteocalcin and gingival crevicular fluid tumour necrosis factor-α in children.

Kâ K, Rousseau MC, Tran SD, Kaartinen MT, Myneni VD, Henderson M, Nicolau B.

J Clin Periodontol. 2014 May;41(5):467-72. doi: 10.1111/jcpe.12232. Epub 2014 Feb 17.

PMID:
24460774
14.

Transglutaminase activity arising from Factor XIIIA is required for stabilization and conversion of plasma fibronectin into matrix in osteoblast cultures.

Cui C, Wang S, Myneni VD, Hitomi K, Kaartinen MT.

Bone. 2014 Feb;59:127-38. doi: 10.1016/j.bone.2013.11.006. Epub 2013 Nov 15.

PMID:
24246248
15.

Cohesive behavior of soft biological adhesives: experiments and modeling.

Dastjerdi AK, Pagano M, Kaartinen MT, McKee MD, Barthelat F.

Acta Biomater. 2012 Sep;8(9):3349-59. doi: 10.1016/j.actbio.2012.05.005. Epub 2012 May 12.

PMID:
22588071
16.

Factor XIIIA transglutaminase expression and secretion by osteoblasts is regulated by extracellular matrix collagen and the MAP kinase signaling pathway.

Piercy-Kotb SA, Mousa A, Al-Jallad HF, Myneni VD, Chicatun F, Nazhat SN, Kaartinen MT.

J Cell Physiol. 2012 Jul;227(7):2936-46. doi: 10.1002/jcp.23040.

PMID:
21959563
17.

Osteoid-mimicking dense collagen/chitosan hybrid gels.

Chicatun F, Pedraza CE, Ghezzi CE, Marelli B, Kaartinen MT, McKee MD, Nazhat SN.

Biomacromolecules. 2011 Aug 8;12(8):2946-56. doi: 10.1021/bm200528z. Epub 2011 Jun 28.

PMID:
21661759
18.

Osteopontin and wound healing in bone.

McKee MD, Pedraza CE, Kaartinen MT.

Cells Tissues Organs. 2011;194(2-4):313-9. doi: 10.1159/000324244. Epub 2011 May 13. Review.

PMID:
21576907
19.

Plasma membrane factor XIIIA transglutaminase activity regulates osteoblast matrix secretion and deposition by affecting microtubule dynamics.

Al-Jallad HF, Myneni VD, Piercy-Kotb SA, Chabot N, Mulani A, Keillor JW, Kaartinen MT.

PLoS One. 2011 Jan 20;6(1):e15893. doi: 10.1371/journal.pone.0015893.

20.

Transglutaminase-mediated oligomerization promotes osteoblast adhesive properties of osteopontin and bone sialoprotein.

Forsprecher J, Wang Z, Goldberg HA, Kaartinen MT.

Cell Adh Migr. 2011 Jan-Feb;5(1):65-72. doi: 10.4161/cam.5.1.13369. Epub 2011 Jan 1.

21.

Periodic beaded-filament assembly of fibronectin on negatively charged surface.

Nelea V, Kaartinen MT.

J Struct Biol. 2010 Apr;170(1):50-9. doi: 10.1016/j.jsb.2010.01.009. Epub 2010 Jan 28.

PMID:
20109553
22.

Regulation of ATPase activity of transglutaminase 2 by MT1-MMP: implications for mineralization of MC3T3-E1 osteoblast cultures.

Nakano Y, Forsprecher J, Kaartinen MT.

J Cell Physiol. 2010 Apr;223(1):260-9. doi: 10.1002/jcp.22034.

PMID:
20049897
23.

Osteopontin functions as an opsonin and facilitates phagocytosis by macrophages of hydroxyapatite-coated microspheres: implications for bone wound healing.

Pedraza CE, Nikolcheva LG, Kaartinen MT, Barralet JE, McKee MD.

Bone. 2008 Oct;43(4):708-16. doi: 10.1016/j.bone.2008.06.010. Epub 2008 Jul 4.

PMID:
18656563
24.

Enhanced osteoblast adhesion on transglutaminase 2-crosslinked fibronectin.

Forsprecher J, Wang Z, Nelea V, Kaartinen MT.

Amino Acids. 2009 Apr;36(4):747-53. doi: 10.1007/s00726-008-0125-7. Epub 2008 Jul 5.

PMID:
18604470
25.

Biogenesis of extracellular microfibrils: Multimerization of the fibrillin-1 C terminus into bead-like structures enables self-assembly.

Hubmacher D, El-Hallous EI, Nelea V, Kaartinen MT, Lee ER, Reinhardt DP.

Proc Natl Acad Sci U S A. 2008 May 6;105(18):6548-53. doi: 10.1073/pnas.0706335105. Epub 2008 Apr 30.

26.

Size distribution and molecular associations of plasma fibronectin and fibronectin crosslinked by transglutaminase 2.

Nelea V, Nakano Y, Kaartinen MT.

Protein J. 2008 Jun;27(4):223-33. doi: 10.1007/s10930-008-9128-1.

PMID:
18330684
27.

ATP-mediated mineralization of MC3T3-E1 osteoblast cultures.

Nakano Y, Addison WN, Kaartinen MT.

Bone. 2007 Oct;41(4):549-61. Epub 2007 Jun 29.

PMID:
17669706
28.

Pyrophosphate inhibits mineralization of osteoblast cultures by binding to mineral, up-regulating osteopontin, and inhibiting alkaline phosphatase activity.

Addison WN, Azari F, Sørensen ES, Kaartinen MT, McKee MD.

J Biol Chem. 2007 May 25;282(21):15872-83. Epub 2007 Mar 23.

29.

Expression and localization of plasma transglutaminase factor XIIIA in bone.

Nakano Y, Al-Jallad HF, Mousa A, Kaartinen MT.

J Histochem Cytochem. 2007 Jul;55(7):675-85. Epub 2007 Mar 6.

PMID:
17341477
30.

Osteopontin upregulation and polymerization by transglutaminase 2 in calcified arteries of Matrix Gla protein-deficient mice.

Kaartinen MT, Murshed M, Karsenty G, McKee MD.

J Histochem Cytochem. 2007 Apr;55(4):375-86. Epub 2006 Dec 22.

PMID:
17189522
31.

Hierarchies of extracellular matrix and mineral organization in bone of the craniofacial complex and skeleton.

McKee MD, Addison WN, Kaartinen MT.

Cells Tissues Organs. 2005;181(3-4):176-88. Review.

PMID:
16612083
32.

Transglutaminase activity regulates osteoblast differentiation and matrix mineralization in MC3T3-E1 osteoblast cultures.

Al-Jallad HF, Nakano Y, Chen JL, McMillan E, Lefebvre C, Kaartinen MT.

Matrix Biol. 2006 Apr;25(3):135-48. Epub 2006 Feb 15.

PMID:
16469487
33.

Transglutaminases in mineralized tissues.

Nurminskaya M, Kaartinen MT.

Front Biosci. 2006 May 1;11:1591-606.

PMID:
16368540
34.

Transglutaminase crosslinking of SIBLING proteins in teeth.

Kaartinen MT, Sun W, Kaipatur N, McKee MD.

J Dent Res. 2005 Jul;84(7):607-12.

PMID:
15972587
35.

Cartilage formation and calcification in arteries of mice lacking matrix Gla protein.

El-Maadawy S, Kaartinen MT, Schinke T, Murshed M, Karsenty G, McKee MD.

Connect Tissue Res. 2003;44 Suppl 1:272-8.

PMID:
12952208
36.

Tissue transglutaminase and its substrates in bone.

Kaartinen MT, El-Maadawy S, Räsänen NH, McKee MD.

J Bone Miner Res. 2002 Dec;17(12):2161-73.

37.

Homotypic interactions of soluble and immobilized osteopontin.

Goldsmith HL, Labrosse JM, McIntosh FA, Mäenpää PH, Kaartinen MT, McKee MD.

Ann Biomed Eng. 2002 Jun;30(6):840-50.

PMID:
12220083
38.

Osteopontin expression and regulation in the testis, efferent ducts, and epididymis of rats during postnatal development through to adulthood.

Luedtke CC, McKee MD, Cyr DG, Gregory M, Kaartinen MT, Mui J, Hermo L.

Biol Reprod. 2002 May;66(5):1437-48.

PMID:
11967208
39.

A mass spectrometric study of metal binding to osteocalcin.

Nousiainen M, Derrick PJ, Kaartinen MT, Mäenpää PH, Rouvinen J, Vainiotalo P.

Chem Biol. 2002 Feb;9(2):195-202.

40.

Cross-linking of osteopontin by tissue transglutaminase increases its collagen binding properties.

Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Mäenpää PH.

J Biol Chem. 1999 Jan 15;274(3):1729-35.

41.

Transglutaminase-catalyzed cross-linking of osteopontin is inhibited by osteocalcin.

Kaartinen MT, Pirhonen A, Linnala-Kankkunen A, Mäenpää PH.

J Biol Chem. 1997 Sep 5;272(36):22736-41.

Supplemental Content

Loading ...
Support Center